Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
Conditions
Interventions
Intervention1: CUQ1720: Oral administration of CUQ1720 400mg capsules twice a day for 28 days in healthy volunteers
Intervention2: CUQ1720: Oral administration of 400mg CUQ1720 capsules along with met
Sponsors
Akay Flavours and Aromatics Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. BMI of 18-30 kg/m2
Exclusion criteria
Exclusion criteria: For Healthy Subjects 1. Fasting Blood Sugar 2. Hb1Ac less than 5.7 % For diabetic Subjects 1. Fasting Blood Sugar >= 120 to 2. Hb1Ac: Greater than 6.5 % 3. Subjects on metformin 500 mg, twice a day, since past 3 months 4. Females of child bearing age, agree to use approved birth control methods during the study, and have negative urine pregnancy test at screening 5. Subject willing to adhere with their routine diet, physical activity, and general lifestyle throughout the study 6. Must be willing and able to give informed consent and comply with the study procedures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in post prandial Blood sugar levelTimepoint: Day 0, Day 28 | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Bio markers, Questionnaire based assessments and over all safety of the SubjectsTimepoint: Day 0, Day 28 | — |
Countries
India
Contacts
Public ContactJestin V Thomas
Leads Clinical Research and Bio Services Pvt. Ltd
Outcome results
None listed